CpG1018

N/A

Report date: 2026/01/27 17:57:44
NME

Base Information

Drug NameCpG1018
Drug Alias NameCpG1018CpG 1018
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideOther > Adjuvant
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsCognitive DysfunctionAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDynavax GmbhNyu Langone Health
China Registration ClassN/A

Develop Information

Active CompaniesNyu Langone Health
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A